Current Cancer Drug Targets
Volume 22, 11 Issues, 2022
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets , Volume 8 - Number 8
mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy
, 8(8): 647 - 665Paolo Baldo, Sara Cecco, Elisa Giacomin, Renzo Lazzarini, Barbara Ros and Stefano Marastoni
DOI: 10.2174/156800908786733513
Anticancer Immunotherapy in Combination with Proapoptotic Therapy
, 8(8): 666 - 675Oystein Bruserud, Elisabeth Ersvaer, Astrid Olsnes and Bjorn Tore Gjertsen
DOI: 10.2174/156800908786733496
Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma
, 8(8): 676 - 682Daniel Y.C. Heng and Ronald M. Bukowski
DOI: 10.2174/156800908786733450
PEDF as an Emerging Therapeutic Candidate for Osteosarcoma
, 8(8): 683 - 690Crispin R. Dass, Eugene T.H. Ek and Peter F.M. Choong
DOI: 10.2174/156800908786733487
Melatonin as a Selective Estrogen Enzyme Modulator
, 8(8): 691 - 702S. Cos, A. Gonzalez, C. Martinez-Campa, M. D. Mediavilla, C. Alonso-Gonzalez and E. J. Sanchez-Barcelo
DOI: 10.2174/156800908786733469
Budesonide and Phenethyl Isothiocyanate Attenuate DNA Damage in Bronchoalveolar Lavage Cells of Mice Exposed to Environmental Cigarette Smoke
, 8(8): 703 - 708Rosanna T. Micale, Francesco D'Agostini, Vernon E. Steele, Sebastiano La Maestra and Silvio De Flora
DOI: 10.2174/156800908786733423
Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells
, 8(8): 709 - 719Monica Banez-Coronel, Ana Ramirez de Molina, Agustin Rodriguez-Gonzalez, Jacinto Sarmentero, Mª Angeles Ramos, Miguel Angel Garcia-Cabezas, Lourdes Garcia-Oroz and Juan Carlos Lacal
DOI: 10.2174/156800908786733432
ADAM Proteins- Therapeutic Potential in Cancer
, 8(8): 720 - 732Xinjie Lu, Dong Lu, Mike Scully and Vijay Kakkar
DOI: 10.2174/156800908786733478
The PIK3CA Gene as a Mutated Target for Cancer Therapy
, 8(8): 733 - 740John P. Gustin, David P. Cosgrove and Ben Ho Park
DOI: 10.2174/156800908786733504
Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data)
, 8(8): 741 - 752Ankur Kumar Upadhyay, Amrendra Kumar Ajay, Sandeep Singh and Manoj Kumar Bhat
DOI: 10.2174/156800908786733405
Protective Effect of NSAIDs on Cancer and Influence of COX-2 C G Genotype
, 8(8): 753 - 764C. Siemes, L. E. Visser, J. W.W. Coebergh, A. Hofman, A. G. Uitterlinden and B.H. Ch. Stricker
DOI: 10.2174/156800908786733414
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
Houston, TX
(USA)
Biography
Center for Drug Discovery
University of Houston
Houston, TX
Biography
Biography of Ruiwen Zhang
Ruiwen Zhang is the Robert L. Boblitt Endowed Professor in Drug Discovery and Director of the Drug Discovery Institute at the University of Houston. With over 30 years of experience in the field of biomedical research, particularly in the area of clinical pharmacology and therapeutics, pharmaceutical and toxicological research, Dr. Zhang’s research has been continuously funded by NIH and DoD, and other agencies. He has published more than 230 papers, 2 books, and more than 50 invited reviews/book chapters as well as more than 180 meeting abstracts. For his outstanding contributions in pharmaceutical sciences, Dr. Zhang was elected as a Fellow of American Association for the Advancement of Science (AAAS) in 2009. Dr. Zhang is recently elected as Fellow of National Academy of Inventors (2018).
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Meet the Executive Guest Editor(s)⇨ Board Recruitment Workflow⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net